Get the Stockscreener App
1.74
2.79%
-0.05
After Hours:
1.75
0.01
+0.57%
Heron Therapeutics Inc Stock (HRTX) Forecast
The Heron Therapeutics Inc (HRTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.5582, representing a +276.91% increase from the current price of $1.74. The highest analyst price target is $9.2901, and the lowest is $3.8263.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HRTX Price Target
Average 4.7569
(+173.39% Upside)
Is Heron Therapeutics Inc (HRTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.51 | Neutral |
| STOCH(9,6) | 48.77 | Neutral |
| STOCHRSI(14) | 11.50 | Buy |
| MACD(12,26) | 0.0514 | Buy |
| ADX(14) | 24.06 | Neutral |
| William %R | -54.55 | Neutral |
| CCI(14) | 3.3347 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.759
Sell
|
1.7513
Sell
|
| MA20 |
1.686
Buy
|
1.7111
Buy
|
| MA50 |
1.5962
Buy
|
1.6626
Buy
|
| MA100 |
1.6741
Buy
|
1.759
Sell
|
| MA200 |
2.2413
Sell
|
1.8749
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, HRTX could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on HRTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.51 indicates that HRTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.77 indicates that HRTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.5 indicates that HRTX is oversold. This suggests that HRTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.06 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 3.3347 indicates that HRTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Heron Therapeutics Inc financial reports and earnings history, Heron Therapeutics Inc (HRTX) stock could reach $12.81 by 2030, $12.78 by 2040 and $34.29 by 2050. See the projected annual prices until 2050 of the Heron Therapeutics Inc stock below:
- Heron Therapeutics Inc (HRTX) is expected to reach an average price of $5.2724 in 2035, with a high prediction of $6.3731 and a low estimate of $5.5424. This indicates an $203.01% rise from the last recorded price of $1.74.
- Heron Therapeutics Inc (HRTX) stock is projected to chart a bullish course in 2040, with an average price target of $12.29, representing an $606.52% surge from its current level. The forecast ranges from a conservative $12.29 to a sky-high $12.78.
- Our analysts predict Heron Therapeutics Inc (HRTX) to jump 1,134% by 2045, soaring from $21.56 to an average price of $21.48, potentially reaching $21.34. While $21.56 is the low estimate, the potential upside is significant.
- Heron Therapeutics Inc (HRTX) stock is expected to climb by 2050, reaching an average of $34.19, a $1,865% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.29 and $33.39, respectively, highlighting the market's uncertainty.
Heron Therapeutics Inc Stock (HRTX) Year by Year Forecast
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2025
Heron Therapeutics Inc Stock (HRTX) is expected to reach an average price of $6.1451 in 2025, with a high prediction of $12.26 and a low estimate of $0.0312. This indicates an +253.16% rise from the last recorded price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $4.5763 | $3.8263 | $9.2901 | +163.00% |
| April, 2025 | $1.6631 | $1.5915 | $5.7924 | -4.42% |
| May, 2025 | $1.8514 | $0.8153 | $2.6453 | +6.40% |
| June, 2025 | $2.2459 | $0.6336 | $2.8759 | +29.07% |
| July, 2025 | $8.3965 | $2.572 | $8.5565 | +382.56% |
| August, 2025 | $3.301 | $0.0312 | $9.4826 | +89.71% |
| September, 2025 | $3.0355 | $2.8655 | $5.8133 | +74.45% |
| October, 2025 | $1.6861 | $1.0861 | $3.854 | -3.10% |
| November, 2025 | $2.9706 | $1.2523 | $4.5234 | +70.73% |
| December, 2025 | $4.6813 | $2.6151 | $5.3513 | +169.04% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2026
The predicted value for Heron Therapeutics Inc (HRTX) in 2026 is set at an average of $5.8897. Estimates vary from a peak of $11.23 to a trough of $0.5469, indicating an +238.49% surge from the present price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.5458 | $4.1074 | $7.9396 | +276.19% |
| February, 2026 | $7.4703 | $5.5419 | $7.5003 | +329.33% |
| March, 2026 | $6.5648 | $6.4748 | $11.23 | +277.29% |
| April, 2026 | $8.1554 | $5.857 | $9.2193 | +368.70% |
| May, 2026 | $4.9899 | $4.7099 | $9.6515 | +186.78% |
| June, 2026 | $6.1244 | $3.726 | $7.1344 | +251.98% |
| July, 2026 | $3.605 | $2.875 | $8.6528 | +107.18% |
| August, 2026 | $5.3395 | $2.8534 | $5.3895 | +206.87% |
| September, 2026 | $4.1901 | $3.9601 | $6.6618 | +140.81% |
| October, 2026 | $2.1546 | $1.9496 | $4.3463 | +23.83% |
| November, 2026 | $2.2091 | $0.5469 | $2.7708 | +26.96% |
| December, 2026 | $1.4698 | $1.4198 | $3.6598 | -15.53% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Heron Therapeutics Inc (HRTX) is $2.2273, with a high forecast of $4.3668 and a low forecast of $0.0878. This indicates an +28.01% increase from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.5143 | $0.8243 | $2.462 | -12.97% |
| February, 2027 | $1.2988 | $1.0004 | $3.8826 | -25.36% |
| March, 2027 | $1.0194 | $0.1229 | $1.4749 | -41.41% |
| April, 2027 | $0.2539 | $0.0878 | $1.9216 | -85.41% |
| May, 2027 | $0.2784 | $0.2177 | $0.9561 | -84.00% |
| June, 2027 | $2.721 | $0.2345 | $2.126 | +56.38% |
| July, 2027 | $2.1265 | $2.4265 | $2.3549 | +22.21% |
| August, 2027 | $2.502 | $2.0242 | $1.782 | +43.79% |
| September, 2027 | $4.0713 | $3.2158 | $3.7713 | +133.99% |
| October, 2027 | $4.4768 | $4.1302 | $4.3668 | +157.29% |
| November, 2027 | $3.7523 | $4.4007 | $4.2985 | +115.65% |
| December, 2027 | $1.5317 | $3.5317 | $4.024 | -11.97% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2028
In 2028, Heron Therapeutics Inc (HRTX) is projected to reach an average price of $2.7217, with a high projection of $3.4377 and a low estimate of $2.0056. This indicates an +56.42% rise from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.5772 | $2.0056 | $2.2972 | +48.12% |
| February, 2028 | $2.2427 | $2.405 | $1.9527 | +28.89% |
| March, 2028 | $2.3821 | $2.3066 | $2.2771 | +36.90% |
| April, 2028 | $3.1776 | $2.986 | $3.0776 | +82.62% |
| May, 2028 | $3.247 | $3.4153 | $3.1603 | +86.61% |
| June, 2028 | $2.6825 | $2.7525 | $3.1908 | +54.16% |
| July, 2028 | $2.818 | $2.888 | $2.7052 | +61.95% |
| August, 2028 | $3.0573 | $2.9018 | $2.8596 | +75.71% |
| September, 2028 | $2.7528 | $3.0512 | $3.144 | +58.21% |
| October, 2028 | $2.3783 | $2.4126 | $2.3733 | +36.69% |
| November, 2028 | $3.4977 | $3.5177 | $3.4377 | +101.02% |
| December, 2028 | $3.2732 | $3.3155 | $3.2516 | +88.12% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2029
The 2029 price forecast for Heron Therapeutics Inc Stock (HRTX) is $6.247 on average, with a high prediction of $12.49 and a low estimate of $0.00292. This represents an +259.02% increase from the previous price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.5426 | $2.6726 | $3.1221 | +46.13% |
| February, 2029 | $2.3481 | $2.4231 | $2.4465 | +34.95% |
| March, 2029 | $2.6236 | $2.342 | $2.4936 | +50.78% |
| April, 2029 | $2.9264 | $2.7645 | $2.6813 | +68.18% |
| May, 2029 | $2.8331 | $2.8545 | $2.8624 | +62.82% |
| June, 2029 | $1.914 | $2.074 | $2.2623 | +10.00% |
| July, 2029 | $1.3495 | $1.4495 | $1.6078 | -22.44% |
| August, 2029 | $0.4088 | $0.4838 | $1.0533 | -76.50% |
| September, 2029 | $0.0343 | $0.0915 | $0.3427 | -98.03% |
| October, 2029 | $0.5663 | $0.00292 | $0.7963 | -67.45% |
| November, 2029 | $0.4208 | $0.1885 | $0.8558 | -75.82% |
| December, 2029 | $13.26 | $0.143 | $12.49 | +661.81% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2030
Heron Therapeutics Inc Stock (HRTX) is expected to reach an average price of $8.7092 in 2030, with a high forecast of $14.57 and a low forecast of $2.8445. This signifies an +400.53% surge from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.91 | $13.66 | $12.81 | +641.94% |
| February, 2030 | $11.78 | $12.78 | $11.93 | +577.05% |
| March, 2030 | $13.66 | $12.06 | $12.10 | +684.96% |
| April, 2030 | $11.20 | $12.53 | $11.46 | +543.84% |
| May, 2030 | $10.58 | $10.29 | $10.89 | +508.13% |
| June, 2030 | $8.9725 | $10.44 | $10.23 | +415.66% |
| July, 2030 | $3.6162 | $7.0912 | $7.2202 | +107.83% |
| August, 2030 | $3.3022 | $2.8445 | $2.279 | +89.78% |
| September, 2030 | $6.4832 | $3.83 | $4.4932 | +272.60% |
| October, 2030 | $6.132 | $5.9687 | $4.722 | +252.41% |
| November, 2030 | $13.96 | $7.0097 | $10.32 | +702.47% |
| December, 2030 | $14.83 | $15.53 | $14.57 | +752.52% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):